| Document Date: 2010-03-29 07:13:09
Open Document File Size: 599,01 KBShare Result on Facebook
Company Hikma Farmacêutica (Portugal) S.A. / / Country United Kingdom / / Event Product Issues / FDA Phase / / IndustryTerm infusion product / Treatment of metastatic colorectal cancer / glucose solution / reference product / injectable solutions / medicinal products / therapeutic / treatment of cancer / medicinal product / treatment of stage III colon cancer / chemical structure / / MedicalCondition tremors / allergic reaction / anaphylactic shock / solid tumours / Dysarthria / acidosis / Meningism / nausea / stomatitis / skin rash / thrombocytopenia / rhinitis / Alopecia / pulmonary fibrosis / Colitis / colon cancer / conjunctivitis / pulmonary / Deafness / hypersensitivity / hepato-biliary disorders / III colon cancer / liver disease / Infections / Back pain / neurologic symptoms / sepsis / DC Hepatic insufficiency / hypotension / nutrition disorders / intestinal obstruction / Epistaxis / necrosis / pulmonary infiltrates / bronchospasm / cancer / peliosis hepatis / Dysgeusia / Optic neuritis / mild renal dysfunction / progressive disease / neutropenia / tumour / metastatic colorectal cancer / Allergy / mucositis / fever / paralytic ileus / vomiting / portal hypertension / urticaria / rigors / infection / dizziness / cough / inflammation / thrombosis / hypokalemia / metastases / Rash / syndrome / interstitial lung disease / disorders / fibrosis / Dehydration / / MedicalTreatment intravenous infusion / surgery / contraception / / Organization PAR Oxaliplatin / MHRA / ml Concentrate for Solution for Infusion PL / / / Position physician / General / / Product granisetron / Oxaliplatin 5 mg / ml Concentrate / Rio / erythromycin / paclitaxel / fluorouracil / Oxaliplatin / liver function tests / Oxaliplatin 5 mg/ml Concentrate / / ProgrammingLanguage DC / /
SocialTag |
PAR Oxaliplatin 5 mg / ml Concentrate for Solution for Infusion PL; UK/HDC Public Assessment Report Decentralised Procedure